2023 cisplatin shortage tied to use of alternatives for head, neck cancer

by Lori SolomonThe 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a study presente

Updated on: October 18,2024

2023 cisplatin shortage tied to use of alternatives for head, neck cancer

by Lori SolomonThe 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a study presente

Updated on:October 18,2024

Study identifies risk factors for early onset colorectal cancer in males

by Regenstrief InstituteCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer incidence and deaths are declining for individuals age 50 and older, but

Updated on: February 18,2024

Study identifies risk factors for early onset colorectal cancer in males

by Regenstrief InstituteCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer incidence and deaths are declining for individuals age 50 and older, but

Updated on:February 18,2024

Researchers uncover novel aspect of tumor evolution and potential targets for therapy

by Ludwig Institute for Cancer ResearchGraphical abstract. Credit:Cell Metabolism(2023). DOI: 10.1016/j.cmet.2022.12.003A Ludwig Cancer Research study has discovered that the immune s

Updated on: January 30,2024

Researchers uncover novel aspect of tumor evolution and potential targets for therapy

by Ludwig Institute for Cancer ResearchGraphical abstract. Credit:Cell Metabolism(2023). DOI: 10.1016/j.cmet.2022.12.003A Ludwig Cancer Research study has discovered that the immune s

Updated on:January 30,2024

Man's best friend leads way to early cancer detection

by Brittany Steff,Purdue UniversityVeterinary oncologist Deborah Knapp studies cancer in Scottish terriers to help advance the science of detecting and treating early cancer in both humans and d

Updated on: January 02,2024

Man's best friend leads way to early cancer detection

by Brittany Steff,Purdue UniversityVeterinary oncologist Deborah Knapp studies cancer in Scottish terriers to help advance the science of detecting and treating early cancer in both humans and d

Updated on:January 02,2024

Study reveals possible solution to elevated cancer risk from important anti-infection drug

by Alex Gardner,Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainFor the last decade, medical experts have known that voriconazole, an effective antifungal m

Updated on: July 02,2024

Study reveals possible solution to elevated cancer risk from important anti-infection drug

by Alex Gardner,Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainFor the last decade, medical experts have known that voriconazole, an effective antifungal m

Updated on:July 02,2024

Opportunistic colonizers: Selectively targeting tumor cells with bacteria

by TranSpreadC@ECN-PL delivers CXB to tumor cells via liposomes anchored to the cell surface and promotes immune cell recruitment to the tumor. The self-lysis circuit ensures that C@ECN-PL does not ac

Updated on: July 08,2024

Opportunistic colonizers: Selectively targeting tumor cells with bacteria

by TranSpreadC@ECN-PL delivers CXB to tumor cells via liposomes anchored to the cell surface and promotes immune cell recruitment to the tumor. The self-lysis circuit ensures that C@ECN-PL does not ac

Updated on:July 08,2024

Advancing neuropathology with AI-driven classification of diffuse gliomas

by Liu Jia,Chinese Academy of SciencesTen examples of classification results on the external testing sets. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-41195-9Diffuse

Updated on: March 30,2024

Advancing neuropathology with AI-driven classification of diffuse gliomas

by Liu Jia,Chinese Academy of SciencesTen examples of classification results on the external testing sets. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-41195-9Diffuse

Updated on:March 30,2024

New bacterial therapy approach to treat lung cancer

by Holly Evarts,Columbia University School of Engineering and Applied ScienceFluorescence microscopy image of lung cancer cells stained with antibodies against proteins involved in cellular grow

Updated on: February 23,2024

New bacterial therapy approach to treat lung cancer

by Holly Evarts,Columbia University School of Engineering and Applied ScienceFluorescence microscopy image of lung cancer cells stained with antibodies against proteins involved in cellular grow

Updated on:February 23,2024

Study quantifies impact of NCI-sponsored trials on clinical cancer care

by National Cancer InstituteA study shows that 82 of 182 phase 3 clinical trials led by SWOG or by other NCTN groups with SWOG participation were 'practice influential'. Credit: National

Updated on: June 28,2024

Study quantifies impact of NCI-sponsored trials on clinical cancer care

by National Cancer InstituteA study shows that 82 of 182 phase 3 clinical trials led by SWOG or by other NCTN groups with SWOG participation were 'practice influential'. Credit: National

Updated on:June 28,2024

Researchers zero in on molecular fingerprint for prostate cancer

by University of South AustraliaCredit: University of South AustraliaSix cancers that claim more than 23,000 Australian lives each year1 should be prioritised for research that makes it possible

Updated on: March 12,2024

Researchers zero in on molecular fingerprint for prostate cancer

by University of South AustraliaCredit: University of South AustraliaSix cancers that claim more than 23,000 Australian lives each year1 should be prioritised for research that makes it possible

Updated on:March 12,2024

Pilot study of 5-hour molecular test accurately distinguishes malignant and benign breast tumors

by Johns Hopkins University School of MedicineInvestigator Bradley Downs assembling cartridge assay that distinguishes cancer from benign aspirates from mammographically suspicious breast lesions

Updated on: March 14,2024

Pilot study of 5-hour molecular test accurately distinguishes malignant and benign breast tumors

by Johns Hopkins University School of MedicineInvestigator Bradley Downs assembling cartridge assay that distinguishes cancer from benign aspirates from mammographically suspicious breast lesions

Updated on:March 14,2024

A common genetic signature has been discovered among three cancer prone rare skin diseases

by Carlos III University of MadridGene expression signature in fibroblasts from RDEB, KS and XPC patients, compared to healthy donors (a). An alteration common to the three diseases of 227 genes

Updated on: April 22,2024

A common genetic signature has been discovered among three cancer prone rare skin diseases

by Carlos III University of MadridGene expression signature in fibroblasts from RDEB, KS and XPC patients, compared to healthy donors (a). An alteration common to the three diseases of 227 genes

Updated on:April 22,2024